- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Skeletal Dysplasia in Japan
Total 16 results
-
Zeria PharmaceuticalCompleted
-
Zeria PharmaceuticalCompleted
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
Zeria PharmaceuticalCompleted
-
Osaka City UniversityCompletedFunctional DyspepsiaJapan
-
Astellas Pharma IncCompletedFunctional Dyspepsia | DyspepsiaJapan
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Disorders | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Adenomatous Polyp | Colorectal Cancer Stage I | Colorectal Adenoma... and other conditionsUnited States, Italy, China, Spain, Japan
-
National Hospital Organization Minami Kyoto HospitalCompletedBreathing-Swallowing Coordination | Dysphagia RehabilitationJapan
-
Hamilton Health Sciences CorporationTehran University of Medical Sciences; Tohoku UniversityRecruitingFunctional Dyspepsia | Peptic Ulcer | Gastro Esophageal Reflux | Normal ControlCanada, Iran, Islamic Republic of, Japan
-
Eisai Co., Ltd.Completed
-
Astex Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Myeloid Dysplastic SyndromeUnited States, Taiwan, Korea, Republic of, Canada, Spain, Japan, Italy, Austria, Denmark
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
OHB Neonatology Ltd.RecruitingIntraventricular Hemorrhage | Bronchopulmonary Dysplasia | Chronic Lung Disease of Prematurity | Retinopathy of Prematurity (ROP)Finland, United States, France, Italy, United Kingdom, Germany, Canada, Ireland, Japan, Netherlands, Portugal, Spain, Sweden
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
Novartis PharmaceuticalsCompletedGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditionsUnited States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Brazil, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel